相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cerebrospinal fluid biomarker for Parkinson's disease: An overview
Fabian Maass et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2019)
Non-motor Parkinson disease: new concepts and personalised management
Nataliya Titova et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
S. Pablo Sardi et al.
MOVEMENT DISORDERS (2018)
Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
Anthony E. Lang et al.
MOVEMENT DISORDERS (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Apolipoprotein D Concentration in Human Plasma during Aging and in Parkinson's Disease: A Cross-Sectional Study
Andreas Waldner et al.
PARKINSONS DISEASE (2018)
Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
Oeystein R. Brekk et al.
SCIENTIFIC REPORTS (2018)
Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts
Ganqiang Liu et al.
LANCET NEUROLOGY (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Combined immunotherapy with anti-insulin resistance therapy as a novel therapeutic strategy against neurodegenerative diseases
Yoshiki Takamatsu et al.
NPJ PARKINSONS DISEASE (2017)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
The BioFIND Study: Characteristics of a Clinically Typical Parkinson's Disease Biomarker Cohort
Un Jung Kang et al.
MOVEMENT DISORDERS (2016)
Junctional proteins of the blood-brain barrier: New insights into function and dysfunction
Svetlana M. Stamatovic et al.
TISSUE BARRIERS (2016)
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
Kaj Blennow et al.
ALZHEIMERS & DEMENTIA (2015)
CSF biomarkers and clinical progression of Parkinson disease
Sara Hall et al.
NEUROLOGY (2015)
Gene Expression Analysis Approach to Establish Possible Links Between Parkinson's Disease, Cancer and Cardiovascular Diseases
Sajjad Karim et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Parkinson's disease, insulin resistance and novel agents of neuroprotection
Iciar Aviles-Olmos et al.
BRAIN (2013)
The Harvard Biomarker Study's big plan
Dara Mohammadi
LANCET NEUROLOGY (2013)
A NETWORK VIEW ON PARKINSON'S DISEASE
Sreedevi Chandrasekaran et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2013)
Chromogranins A and B are key proteins in amine accumulation, but the catecholamine secretory pathway is conserved without them
Jesica Diaz-Vera et al.
FASEB JOURNAL (2012)
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease
Valerio Pisani et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Dysregulated expression of secretogranin III is involved in neurotoxin-induced dopaminergic neuron apoptosis
Fengrui Li et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Dementia is associated with Insulin Resistance in patients with Parkinson's Disease
Domenico Bosco et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
Identification and proteomic profiling of exosomes in human cerebrospinal fluid
Jonathan M. Street et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Opposite Roles of Furin and PC5A in N-Cadherin Processing
Deborah Maret et al.
NEOPLASIA (2012)
The Extended Granin Family: Structure, Function, and Biomedical Implications
Alessandro Bartolomucci et al.
ENDOCRINE REVIEWS (2011)
Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach
Yvonne J. K. Edwards et al.
PLOS ONE (2011)
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases
Cristina Cocco et al.
JOURNAL OF ANATOMY (2010)
The Neurosecretory Vesicle Protein Phogrin Functions as a Phosphatidylinositol Phosphatase to Regulate Insulin Secretion
Leslie A. Caromile et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Chromogranin B Gene Ablation Reduces the Catecholamine Cargo and Decelerates Exocytosis in Chromaffin Secretory Vesicles
Jesica Diaz-Vera et al.
JOURNAL OF NEUROSCIENCE (2010)
Surface Expression of Precursor N-cadherin Promotes Tumor Cell Invasion
Deborah Maret et al.
NEOPLASIA (2010)
Identification of Glutathione S-Transferase Pi as a Protein Involved in Parkinson Disease Progression
Min Shi et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients
Jiguang Guo et al.
CELL RESEARCH (2009)
Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach
Ashima Sinha et al.
CLINICA CHIMICA ACTA (2009)
Striatal Alterations of Secretogranin-1, Somatostatin, Prodynorphin, and Cholecystokinin Peptides in an Experimental Mouse Model of Parkinson Disease
Anna Nilsson et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
Da Wei Huang et al.
NUCLEIC ACIDS RESEARCH (2009)
Mortalin: A protein associated with progression of Parkinson disease?
Min Shi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
The crucial role of chromogranins in storage and exocytosis revealed using chromaffin cells from chromogranin a null mouse
Monica S. Montesinos et al.
JOURNAL OF NEUROSCIENCE (2008)
Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: Implications for drug therapy
Brinda S. Desai et al.
CELL TRANSPLANTATION (2007)
Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics
SJ Callister et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF
U Rüetschi et al.
EXPERIMENTAL NEUROLOGY (2005)
Regulation of cadherin-mediated adhesion in morphogenesis
BM Gumbiner
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
A human granin-like neuroendocrine peptide precursor (proSAAS) immunoreactivity in tau inclusions of Alzheimer's disease and parkinsonism-dementia complex on Guam
M Wada et al.
NEUROSCIENCE LETTERS (2004)
Targeted disruption of the IA-2β gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice
A Kubosaki et al.
DIABETES (2004)
An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick's disease
K Kikuchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
Mechanisms of disease - The chromogranin-secretogranin family.
L Taupenot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The lumenal domain of the integral membrane protein phogrin mediates targeting to secretory granules
C Wasmeier et al.
TRAFFIC (2002)
Up-regulation of secretoneurin immunoreactivity and secretogranin II mRNA in rat striatum following 6-hydroxydopamine lesioning and chronic L-dopa treatment
AD Medhurst et al.
NEUROSCIENCE (2001)
分享论文
